Lippi Giuseppe, Chiozza Laura, Mattiuzzi Camilla, Plebani Mario
Section of Clinical Biochemistry, University of Verona, Verona, Italy and Associate Editor of Diagnosis.
Service of Clinical Governance, General Hospital of Trento, Trento, Italy.
J Med Biochem. 2017 Apr 22;36(2):107-112. doi: 10.1515/jomb-2017-0003. eCollection 2017 Apr.
Patient and sample misidentification may cause significant harm or discomfort to the patients, especially when incorrect data is used for performing specific healthcare activities. It is hence obvious that efficient and quality care can only start from accurate patient identification. There are many opportunities for misidentification in healthcare and laboratory medicine, including homonymy, incorrect patient registration, reliance on wrong patient data, mistakes in order entry, collection of biological specimens from wrong patients, inappropriate sample labeling and inaccurate entry or erroneous transmission of test results through the laboratory information system. Many ongoing efforts are made to prevent this important healthcare problem, entailing streamlined strategies for identifying patients throughout the healthcare industry by means of traditional and innovative identifiers, as well as using technologic tools that may enhance both the quality and efficiency of blood tubes labeling. The aim of this article is to provide an overview about the liability of identification errors in healthcare, thus providing a pragmatic approach for diverging the so-called patient identification crisis.
患者和样本的误识别可能会给患者带来重大伤害或不适,尤其是在使用错误数据进行特定医疗活动时。因此,显而易见的是,高效且优质的护理只能从准确识别患者开始。在医疗保健和检验医学中,存在许多误识别的机会,包括同名、患者登记错误、依赖错误的患者数据、医嘱录入错误、从错误患者采集生物标本、样本标签不当以及检验结果通过实验室信息系统录入不准确或传输错误。目前正在做出许多努力来预防这一重要的医疗保健问题,这需要通过传统和创新标识符在整个医疗行业采用简化的患者识别策略,以及使用可以提高血样管标签质量和效率的技术工具。本文旨在概述医疗保健中识别错误的责任,从而提供一种务实的方法来化解所谓的患者识别危机。